Literature DB >> 10083842

Antineoplastic agents. III: Steroidal glycosides from Solanum nigrum.

K Hu1, H Kobayashi, A Dong, Y Jing, S Iwasaki, X Yao.   

Abstract

By bioactivity-guided fractionation, three known steroidal glycosides, beta 2-solamargine (1), solamargine (2), and degalactotigonin (3), were isolated from Solanum nigrum. Compounds 1-3 induced morphological abnormality in Pyricularia oryzae mycelia with MMDC (minimum morphological deformation concentration) values of 63.0, 38.5, and 97.2 microM, respectively. This is the first report on the isolation of 1 from this species and on the cytotoxicity of 1-3 on six cultured human solid tumor cell lines HT-29 (colon), HCT-15 (colon), LNCaP (prostate), PC-3 (prostate), T47D (breast), and MDA-MB-231 (breast) in vitro. The cytotoxic assay indicated that 2 is the main antineoplastic agent in S. nigrum. The structures of 1-3 were elucidated on the basis of chemical evidence and spectral analysis, especially by 2D-NMR analysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10083842     DOI: 10.1055/s-1999-13958

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  15 in total

Review 1.  Chemistry of trisdecacyclic pyrazine antineoplastics: the cephalostatins and ritterazines.

Authors:  Seongmin Lee; Thomas G LaCour; Philip L Fuchs
Journal:  Chem Rev       Date:  2009-06       Impact factor: 60.622

2.  Solamargine triggers hepatoma cell death through apoptosis.

Authors:  Xiaodong Xie; Haitao Zhu; Huijian Yang; Wensi Huang; Yingying Wu; Ying Wang; Yanling Luo; Dongqing Wang; Genbao Shao
Journal:  Oncol Lett       Date:  2015-05-11       Impact factor: 2.967

3.  Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.

Authors:  Jean-San Chia; Jia-Ling Du; Wei-Bin Hsu; Andy Sun; Chun-Pin Chiang; Won-Bo Wang
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

4.  In vitro and in vivo hepatoprotective effects of the total alkaloid fraction of Hygrophila auriculata leaves.

Authors:  Vasanth P Raj; Raghu H Chandrasekhar; Vijayan P; Dhanaraj S A; Mallikarjuna C Rao; Venkata J Rao; K Nitesh
Journal:  Indian J Pharmacol       Date:  2010-04       Impact factor: 1.200

5.  Laboratory evaluation of molluscicidal & mosquito larvicidal activities of leaves of Solanum nigrum L.

Authors:  Anjali Rawani; Anupam Ghosh; Goutam Chandra
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

6.  Stimulatory effects of polysaccharide fraction from Solanum nigrum on RAW 264.7 murine macrophage cells.

Authors:  Faizan Naeem Razali; Amirah Ismail; Nurhayati Zainal Abidin; Adawiyah Suriza Shuib
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

7.  Evaluation of uttroside B, a saponin from Solanum nigrum Linn, as a promising chemotherapeutic agent against hepatocellular carcinoma.

Authors:  Lekshmi R Nath; Jaggaiah N Gorantla; Arun Kumar T Thulasidasan; Vinod Vijayakurup; Shabna Shah; Shabna Anwer; Sophia M Joseph; Jayesh Antony; Kollery Suresh Veena; Sankar Sundaram; Udaya K Marelli; Ravi S Lankalapalli; Ruby John Anto
Journal:  Sci Rep       Date:  2016-11-03       Impact factor: 4.379

8.  Solanum Incanum Extract Downregulates Aldehyde Dehydrogenase 1-Mediated Stemness and Inhibits Tumor Formation in Ovarian Cancer Cells.

Authors:  Yi-Hui Wu; Wen-Tai Chiu; Ming-Jer Young; Tzu-Hao Chang; Yu-Fang Huang; Cheng-Yang Chou
Journal:  J Cancer       Date:  2015-08-22       Impact factor: 4.207

9.  Aqueous Extract of Solanum nigrum Leaves Induces Autophagy and Enhances Cytotoxicity of Cisplatin, Doxorubicin, Docetaxel, and 5-Fluorouracil in Human Colorectal Carcinoma Cells.

Authors:  Chen-Jei Tai; Chien-Kai Wang; Cheng-Jeng Tai; Yi-Feng Lin; Chi-Shian Lin; Jiun-Yu Jian; Yu-Jia Chang; Chun-Chao Chang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-17       Impact factor: 2.629

10.  Integrated Treatment of Aqueous Extract of Solanum nigrum-Potentiated Cisplatin- and Doxorubicin-Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells.

Authors:  Chien-Kai Wang; Yi-Feng Lin; Cheng-Jeng Tai; Chia-Wowi Wang; Yu-Jia Chang; Chen-Yen Choong; Chi-Shian Lin; Chen-Jei Tai; Chun-Chao Chang
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.